Federation Des Caisses Desjardins Du Quebec Invitae Corp Transaction History

Federation Des Caisses Desjardins Du Quebec

$17.5 Billion
Q2 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.01 - $0.61 $1 - $112	185 New	185 $2,000
Q3 2023 Aug 14, 2024	SELL	$0.6 - $1.53 $138 - $351	-230 Reduced 55.42%	185 $112,000
Q1 2022 Aug 14, 2024	BUY	$6.28 - $15.59 $2,606 - $6,469	415 New	415 $3.31 Million
Q2 2021 Aug 30, 2024	BUY	$26.09 - $40.4 $10,827 - $16,766	415 New	415 $14 Million
Q1 2021 Aug 30, 2024	BUY	$33.06 - $56.93 $16,034 - $27,611	485 Added 210.87%	715 $27.3 Million
Q1 2020 Aug 30, 2024	BUY	$7.64 - $27.5 $1,757 - $6,325	230 New	230 $3.14 Million
Q3 2019 Aug 30, 2024	SELL	$18.85 - $27.5 $1,413 - $2,062	-75 Closed	0 $0
Q2 2019 Aug 30, 2024	BUY	$17.37 - $26.27 $1,302 - $1,970	75 New	75 $1.76 Million

Others Institutions Holding NVTA

# of Institutions

Shares Held

2.12M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account